Christopher Koivisto to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Christopher Koivisto has written about Drug Resistance, Neoplasm.
Connection Strength
0.589
-
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia. 2020 10; 22(10):484-496.
Score: 0.589